Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
January 21, 2025
From CNBC.com News
Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot
January 21, 2025
From Benzinga
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
January 21, 2025
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
From CNBC.com News
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
January 16, 2025
From Benzinga
Medicare's new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
January 16, 2025
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
From CNBC.com News
Eli Lilly Scoops Up Scorpion Therapeutics' Early-Stage Cancer Program For $2.5 Billion
January 13, 2025
From Benzinga
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
January 10, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
From Benzinga
Stock Of The Day: Will Johnson & Johnson Take The Market Lower?
January 06, 2025
Tickers
JNJ
From Benzinga
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.